These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 2718218
1. Individual variability of amiodarone distribution in plasma and erythrocytes: implications for therapeutic monitoring. Maling TJ, Siebers RW, Burgess CD, Taylor C, Purdie G. Ther Drug Monit; 1989; 11(2):121-6. PubMed ID: 2718218 [Abstract] [Full Text] [Related]
2. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels]. Nitsch J, Lüderitz B. Dtsch Med Wochenschr; 1984 Mar 30; 109(13):492-5. PubMed ID: 6423357 [Abstract] [Full Text] [Related]
3. Plasma and red blood cell concentrations of amiodarone during chronic therapy. Heger JJ, Solow EB, Prystowsky EN, Zipes DP. Am J Cardiol; 1984 Mar 15; 53(7):912-7. PubMed ID: 6538381 [Abstract] [Full Text] [Related]
4. Concentration response relationships of amiodarone and desethylamiodarone. Connolly SJ, Gupta RN, Hoffert D, Roberts RS. Am Heart J; 1988 Jun 15; 115(6):1208-13. PubMed ID: 3376838 [Abstract] [Full Text] [Related]
5. The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy. Burgess CD, Siebers RW, Purdie GL, Taylor C, Maling TJ. Eur J Clin Pharmacol; 1987 Jun 15; 33(2):115-8. PubMed ID: 3691605 [Abstract] [Full Text] [Related]
6. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment. Baerman JM, Annesley T, DiCarlo LA, Foley MK, Nicklas JM, Crevey BJ, Morady F. Am Heart J; 1986 Apr 15; 111(4):644-8. PubMed ID: 3953386 [Abstract] [Full Text] [Related]
7. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure. Candinas R, Frielingsdorf J, Ha HR, Carrel T, Turina M, Follath F. Eur J Clin Pharmacol; 1998 Jan 15; 53(5):331-6. PubMed ID: 9516032 [Abstract] [Full Text] [Related]
8. Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation. Giardina EG, Schneider M, Barr ML. J Am Coll Cardiol; 1990 Oct 15; 16(4):943-7. PubMed ID: 2212375 [Abstract] [Full Text] [Related]
11. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion. Somani P, Simon VA, McManus K. Can J Cardiol; 1985 Jan 15; 1(1):56-65. PubMed ID: 3850764 [Abstract] [Full Text] [Related]
13. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Brien JF, Jimmo S, Brennan FJ, Armstrong PW, Abdollah H. Drug Metab Dispos; 1990 Jan 15; 18(6):846-51. PubMed ID: 1981527 [Abstract] [Full Text] [Related]
19. Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration. Hrudikova Vyskocilova E, Grundmann M, Duricova J, Kacirova I. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun 15; 161(2):134-143. PubMed ID: 28414390 [Abstract] [Full Text] [Related]
20. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy. Naganuma M, Shiga T, Nishikata K, Tsuchiya T, Kasanuki H, Fujii E. J Cardiovasc Pharmacol Ther; 2001 Oct 15; 6(4):363-7. PubMed ID: 11907638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]